Ganglioside embedded in reconstituted lipoprotein binds cholera toxin with elevated affinity

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2731-2738

  Bricarello, Daniel A ^a   Mills, Emily J ^a   Petrlova, Jitka ^b   Voss, John C ^b   Parikh, Atul N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Binding affinity; GM1; Inhibition of toxin binding; Pathogen; Reconstituted high density lipoprotein

Indexed keywords

APOLIPOPROTEIN A1; CHOLERA TOXIN; CHOLERA TOXIN RECEPTOR; GANGLIOSIDE GM1; HIGH DENSITY LIPOPROTEIN; LIPOSOME; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CELL PROTECTION; CONTROLLED STUDY; EPIFLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMAN; HUMAN CELL; LIPID BILAYER; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN ENGINEERING; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; TOXIN ANALYSIS;

APOLIPOPROTEIN A-I; CELLS, CULTURED; CHOLERA TOXIN; FLUORESCENCE RESONANCE ENERGY TRANSFER; GANGLIOSIDES; HUMANS; LIPID BILAYERS; LIPOPROTEINS; LIPOSOMES; PROTEIN BINDING; RETINAL PIGMENT EPITHELIUM;

EID: 77956842258     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M007401     Document Type: Article

References (46)

1. Aderem, A., and R. Ulevitch. 2000. Toll-like receptors in the induction of the innate immune response. Nature. 406: 782-787.
2. Gershoni, J. M. 2008. Molecular decoys: antidotes, therapeutics and immunomodulators. Curr. Opin. Biotechnol. 19: 644-651.
3. Iwamori, M., K. Takamizawa, M. Momoeda, Y. Iwamori, and Y. Taketani. 2008. Gangliosides in human, cow and goat milk, and their abilities as to neutralization of cholera toxin and botulinum type A neurotoxin. Glycoconj. J. 25: 675-683.
4. Newburg, D. S. 1996. Oligosaccharides and glycoconjugates in human milk: their role in host defense. J. Mammary Gland Biol. Neoplasia. 1: 271-283.
5. Hamosh, M., J. A. Peterson, T. R. Henderson, C. D. Scallan, R. Kiwan, R. L. Ceriani, M. Armand, N. R. Mehta, and P. Hamosh. 1999. Protective function of human milk: the milk fat globule. Semin. Perinatol. 23: 242-249.
6. Duncan, R. 2003. The dawning era of polymer therapeutics. Nat. Rev. Drug Discov. 2: 347-360.
7. Jonas, A., and D. J. Krajnovich. 1977. Interaction of human and bovine A-1 apolipoproteins with L-alpha-dimyristoyl phosphadicylcholine and L-alpha-myristoyl lysophosphatidylcholine. J. Biol. Chem. 252: 2194-2199.
8. Vinchurkar, M. S., D. A. Bricarello, J. O. Lagerstedt, J. P. Buban, H. Stahlberg, M. N. Oda, J. C. Voss, and A. N. Parikh. 2008. Bridging across length scales: multi-scale ordering of supported lipid bilayers via lipoprotein self-assembly and surface patterning. J. Am. Chem. Soc. 130: 11164-11169.
9. Guo, L. S., R. L. Hamilton, J. Goerke, J. N. Weinstein, and R. J. Havel. 1980. Interaction of unilamellar liposomes with serum lipoproteins and apolipoproteins. J. Lipid Res. 21: 993-1003.
10. Whorton, M. R., M. P. Bokoch, S. G. Rasmussen, B. Huang, R. N. Zare, B. Kobilka, and R. K. Sunahara. 2007. A monomeric G protein-coupled receptor isolated in a high-density lipoprotein particle efficiently activates its G protein. Proc. Natl. Acad. Sci. USA. 104: 7682-7687.
11. Bayburt, T. H., A. J. Leitz, G. Xie, D. D. Oprian, and S. G. Sligar. 2007. Transducin activation by nanoscale lipid bilayers containing one and two rhodopsins. J. Biol. Chem. 282: 14875-14881.
12. Bayburt, T. H., J. W. Carlson, and S. G. Sligar. 1998. Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J. Struct. Biol. 123: 37-44.
13. Baker, S. E., R. C. Hopkins, C. D. Blanchette, V. L. Walsworth, R. Sumbad, N. O. Fischer, E. A. Kuhn, M. Coleman, B. A. Chromy, S. E. Letant, et al. 2009. Hydrogen production by a hyperthermophilic membrane-bound hydrogenase in water-soluble nanolipoprotein particles. J. Am. Chem. Soc. 131: 7508-7509.
14. Bayburt, T. H., and S. G. Sligar. 2003. Self-assembly of single integral membrane proteins into soluble nanoscale phospholipid bilayers. Protein Sci. 12: 2476-2481.
15. Rensen, P. C., R. L. de Vrueh, J. Kuiper, M. K. Bijsterbosch, E. A. Biessen, and T. J. van Berkel. 2001. Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv. Drug Deliv. Rev. 47: 251-276.
16. Feng, M., Q. Cai, X. Shi, H. Huang, P. Zhou, and X. Guo. 2008. Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells. J. Drug Target. 16: 502-508
17. Newton, R. S., and B. R. Krause. 2002. HDL therapy for the acute treatment of atherosclerosis. Atheroscler. Suppl. 3: 31-38.
18. Wu, J., M. Nantz, and M. Zern. 2002. Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front. Biosci. 7: d 717-725.
19. Kader, A., and A. Pater. 2002. Loading anticancer drugs into HDL as well as LDL has little affect on properties of complexes and enhances cytotoxicity to human carcinoma cells. J. Control. Release. 80: 29-44.
20. Brown, D., and E. London. 2000. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J. Biol. Chem. 275: 17221-17224.
21. Merritt, E. A., S. Sarfaty, F. V. D. Akker, C. L'Hoir, J. A. Martial, and W. G. J. Hol. 1994. Crystal structure of cholera toxin B-pentamer bound to receptor G (M1) pentasaccharide. Protein Sci. 3: 166-175.
22. Miller, C. E., J. Majewski, R. Faller, S. Satija, and T. L. Kuhl. 2004. Cholera toxin assault on lipid monolayers containing ganglioside GM1. Biophys. J. 86: 3700-3708.
23. Sharom, F. J., and C. W. M. Grant. 1978. Model for ganglioside behavior in cell-membranes. Biochim. Biophys. Acta. 507: 280-293.
24. Yuan, C., J. Furlong, P. Burgos, and L. J. Johnston. 2002. The size of lipid rafts: an atomic force microscopy study of ganglioside GM1 domains in sphingomyelin/DOPC/cholesterol membranes. Biophys. J. 82: 2526-2535.
25. Shi, J., T. Yang, S. Kataoka, Y. Zhang, A. J. Diaz, and P. S. Cremer. 2007. GM (1) clustering inhibits cholera toxin binding in supported phospholipid membranes. J. Am. Chem. Soc. 129: 5954-5961.
26. Ryan, R. O., T. M. Forte, and M. N. Oda. 2003. Optimized bacterial expression of human apolipoprotein AI. Protein Expr. Purif. 27: 98-103.
27. Oda, M. N., T. M. Forte, R. O. Ryan, and J. C. Voss. 2003. Apolipoprotein A-1's C-terminal domain contains a lipid sensitive conformational trigger. Nat. Struct. Biol. 10: 455-460.
28. Davenport, L., R. Dale, R. Bisby, and R. Cundall. 1985. Transverse location of the fluorescent probe 1, 6-diphenyl-1, 3, 5-hexatriene in model lipid bilayer membrane systems by resonance excitation energy transfer. Biochemistry. 24: 4097-4108.
29. Lakowicz, J. R. 2006. Principles of Fluorescence Spectroscopy. Springer, New York.
30. Kong, H. J., T. Boontheekul, and D. J. Mooney. 2006. Quantifying the relation between adhesion ligand-receptor bond formation and cell phenotype. Proc. Natl. Acad. Sci. USA. 103: 18534-18539.
31. Lauer, S., B. Goldstein, R. L. Nolan, and J. P. Nolan. 2002. Analysis of cholera toxin-ganglioside interactions by flow cytometry. Biochemistry. 41: 1742-1751.
32. Lincoln, J. E., M. Boling, A. N. Parikh, Y. Yeh, D. G. Gilchrist, and L. S. Morse. 2006. Fas signaling induces raft coalescence that is blocked by cholesterol depletion in human RPE cells undergoing apoptosis. Invest. Ophthalmol. Vis. Sci. 47: 2172-2178.
33. Yee, C. K., M. L. Amweg, and A. N. Parikh. 2004. Direct photochemical patterning and refunctionalization of supported phospholipid bilayers. J. Am. Chem Soc. 126: 13962-13972.
34. Williams, T. L., and A. T. Jenkins. 2008. Measurement of the binding of cholera toxin to GM1 gangliosides on solid supported lipid bilayer vesicles and inhibition by europium (III) chloride. J. Am. Chem. Soc. 130: 6438-6443.
35. Borch, J., F. Torta, S. Sligar, and P. Roepstorff. 2008. Nanodiscs for immobilization of lipid bilayers and membrane receptors: Kinetic analysis of cholera toxin binding to a glycolipid receptor. Anal. Chem. 80: 6245-6252.
36. Tall, A. R., D. M. Small, R. J. Deckelbaum, and G. G. Shipley. 1977. Structure and thermodynamic properties of high density lipoprotein recombinants. J. Biol. Chem. 252: 4701-4711.
37. Edwards, W. L., S. F. Bush, T. W. Mattingly, and K. H. Weisgraber. 1993. Raman spectroscopic study of boundary lipid in 1,2- dipalmitoylphosphatidylcholine/apolipoprotein A-I recombinants. Spectrochim. Acta [A]. 49: 2027-2038.
38. Burger, K., G. Gimpl, and F. Fahrenholz. 2000. Regulation of receptor function by cholesterol. Cell. Mol. Life Sci. 57: 1577-1592.
39. Chachisvilis, M., Y. L. Zhang, and J. A. Frangos. 2006. G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc. Natl. Acad. Sci. USA. 103: 15463-15468.
40. Jonas, A., D. Krajnovich, and B. Patterson. 1977. Physical properties of isolated complexes of human and bovine AI apolipoproteins with L-alpha-dimyristoyl phosphatidylcholine. J. Biol. Chem. 252: 2200-2205.
41. Duncan, K. G., K. R. Bailey, J. P. Kane, and D. M. Schwartz. 2002. Human retinal pigment epithelial cells express scavenger receptors BI and BII. Biochem. Biophys. Res. Commun. 292: 1017-1022.
42. Hayes, K. C., S. Lindsey, Z. F. Stephan, and D. Brecker. 1989. Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest. Ophthalmol. Vis. Sci. 30: 225-232.
43. Tserentsoodol, N., N. Gordiyenko, I. Pascual, J. Lee, S. Fliesler, and I. Rodriguez. 2006. Intraretinal lipid transport is dependent on high density lipoprotein-like particles and class B scavenger receptors. Mol. Vis. 12: 1319-1333.
44. Febbraio, M., D. P. Hajjar, and R. L. Silverstein. 2001. CD36: a class B scavenger receptor involved in angiogenesis, atherosclerosis, inflammation, and lipid metabolism. J. Clin. Invest. 108: 785-791.
45. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature. 387: 569-572.
46. Thompson, T. E., M. Allietta, R. E. Brown, M. L. Johnson, and T. W. Tillack. 1985. Organization of ganglioside GM1 in phosphatidylcholine bilayers. Biochim. Biophys. Acta. 817: 229-237.